NOK 14.0
(-6.35%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -35.25 Million NOK | -101.74% |
2022 | -17.47 Million NOK | -10.08% |
2021 | -15.87 Million NOK | -479.32% |
2020 | -2.74 Million NOK | 58.19% |
2019 | -6.55 Million NOK | 25.45% |
2018 | -8.79 Million NOK | -156.29% |
2017 | -3.43 Million NOK | 31.31% |
2016 | -4.99 Million NOK | 33.35% |
2015 | -7.49 Million NOK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -18.39 Million NOK | -43.24% |
2024 Q1 | -12.84 Million NOK | 12.06% |
2023 Q3 | -7.02 Million NOK | 13.91% |
2023 Q1 | -6.53 Million NOK | 25.36% |
2023 Q4 | -14.6 Million NOK | -107.78% |
2023 FY | -35.25 Million NOK | -101.74% |
2023 Q2 | -8.16 Million NOK | -25.03% |
2022 Q4 | -8.74 Million NOK | -4258.46% |
2022 Q2 | -1.97 Million NOK | 0.0% |
2022 FY | -17.47 Million NOK | -10.08% |
2022 Q3 | -200.72 Thousand NOK | 89.86% |
2021 FY | -15.87 Million NOK | -479.32% |
2020 FY | -2.74 Million NOK | 58.19% |
2019 FY | -6.55 Million NOK | 25.45% |
2018 FY | -8.79 Million NOK | -156.29% |
2017 FY | -3.43 Million NOK | 31.31% |
2016 FY | -4.99 Million NOK | 33.35% |
2015 FY | -7.49 Million NOK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Gentian Diagnostics ASA | -10.64 Million NOK | -231.125% |
Medistim ASA | 103.82 Million NOK | 133.96% |